12S136: ACR Guidelines for Vaccination in Patients with Rheumatic and Musculoskeletal Diseases

Saturday, November 12, 2022

4:30 PM – 5:30 PM Eastern Time

Location: Exhibit Hall A

CE: 1

All of the relevant financial relationships listed for faculty have been mitigated.

Moderator(s)

LI

Lisa Imundo, MD

New York Presbyterian Hospital - Columbia Campus
New York, NY, United States

Disclosure(s): No financial relationships to disclose
Leonard Calabrese, DO

Board Certified Rheumatologist and the Head, Section of Clinical Immunology Department of Rheumatic & Immunologic Disease
Cleveland Clinic
Cleveland, OH, United States

Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); AstraZeneca: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Chemocentryx: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Jansen: Advisor or Review Panel Member (Ongoing); Novartis: Consultant (Ongoing); UCB: Consultant (Ongoing)

This session will introduce participants to the newly compiled guideline for vaccination in patients with rheumatic and musculoskeletal diseases. The guideline was derived from a standardized protocol of developing relevant clinical questions about vaccinations in these populations, followed by an extensive literature review. Evidence summaries from the literature review were then used to develop a guideline to assist providers and patients to plan vaccination strategies with respect to disease activity and use of immunosuppressant medications. The session will review the methods utilized to develop the guideline and the guideline recommendations.

Learning Objectives:

To understand the methodology used to develop the vaccine guideline and recognize the limitations of the published evidence.
To discuss recommendations for expanded vaccine indications for patients with rheumatic diseases taking immunosuppressive medications.
To understand how to manage medications at the time of non-live and live-attenuated vaccination in patients with rheumatic diseases.

Presentations:

4:30 PM – 4:40 PM Eastern Time

Overview of Guideline for Vaccination in Patients with Rheumatic Diseases
Speaker: Anne Bass, MD – Hospital for Special Surgery, Weill Cornell Medicine
4:40 PM – 4:50 PM Eastern Time

Expanded Recommendation for Vaccines in Patients with Rheumatic and Musculoskeletal Diseases
Speaker: Clifton O. Bingham, III, MD – Johns Hopkins University
4:50 PM – 5:00 PM Eastern Time

Medication Management at the Time of Non-Live-Attenuated Vaccination
Speaker: Kevin Winthrop, MD, MPH – Oregon Health & Science University
5:00 PM – 5:10 PM Eastern Time

Medication Management at the Time of Live-Attenuated Vaccines
Speaker: Anne Bass, MD – Hospital for Special Surgery, Weill Cornell Medicine
5:10 PM – 5:30 PM Eastern Time

Panel Discussion/Q&A
Panelist: Anne Bass, MD – Hospital for Special Surgery, Weill Cornell Medicine
Panelist: Clifton O. Bingham, III, MD – Johns Hopkins University
Panelist: Kevin Winthrop – Oregon Health & Science University